Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s share price rose 21.2% during mid-day trading on Friday . The company traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares were traded during mid-day trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a market cap of C$27.89 million, a P/E ratio of -20.00 and a beta of 0.32. The company’s fifty day moving average is C$0.10 and its 200 day moving average is C$0.07. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Stock Analyst Ratings and Canadian Analyst Ratings
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Pros And Cons Of Monthly Dividend Stocks
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Insider Buying Explained: What Investors Need to Know
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
